
Publications
This section collects the most significant scientific contents of EGOI-PCOS members concerning the use of inositols alone or in association, both in basic research and for clinical application.
Also, the most relevant and updated literature on diagnosis and therapy of PCOS is gathered.
In particular, this collection includes the most recent original articles, clinical trials, reviews and meta-analyzes on the use of inositols especially in the gynecological, reproductive, metabolic, and endocrine fields.
Manuscripts inserted deal with important issues such as Polycystic Ovary Syndrome (PCOS), metabolic syndrome, insulin resistance, gestational diabetes with its complications, neurological defects for the unborn children linked to the nutritional deficiencies of mothers.
Inositols and Bone Health: Potential Therapeutic Applications in Osteoporosis Prevention and Treatment
Authors: Cipriani, F.; Gnessi, L.; Watanabe, M.; Baldelli, R.
PCOS and Inositols – Advances and Lessons We are Learning. A Narrative Review.
Authors: Lentini G, Querqui A, Monti N, Bizzarri M.
Insights from the EGOI-PCOS patient survey: Diagnosis, treatment, and quality of life according to Italian PCOS patients
Authors: Carriero VC, Forte G, Dinicola S, Oliva MM, Al Mudarris G., Unfer V.
Endocrine Metabolic Syndrome and Metabolic Syndrome: Distinct but Interrelated Pathologies
Authors: Myers SH, Soulage CO, Unfer V.
D-chiro-inositol effectively counteracts endometriosis in a mouse model
Authors: Placidi M, Casoli G, Vergara T, Bianchi A, Cocciolone D, Zaccardi S, Macchiarelli G, Palmerini MG, Tatone C, Bevilacqua A, Di Emidio G.
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases
Authors: Quecchia C, Vianello A.
Unexpected effects of treating insulin-resistant obese women with high-dose D-chiro-inositol: opening Pandora’s box
Authors: Sabrina Basciani, Maurizio Nordio, Maria Letizia Spizzichini and Lucio Gnessi
A retrospective study “myo-inositol is a cost-saving strategy for controlled ovarian stimulation in non-polycystic ovary syndrome art patients.”
Authors: Aragona C, Russo M, Myers SH, Espinola MSB, Bilotta G, Unfer V.
Gestational diabetes mellitus and polycystic ovary syndrome, a position statement from EGOI-PCOS
Authors: Quaresima P, Myers SH, Pintaudi B, D’Anna R, Morelli M and Unfer V
Delphi consensus on the diagnostic criteria of polycystic ovary syndrome
Authors: Fabio Facchinetti, Alessandra Gambineri, Gianluca Aimaretti, Alberto Ferlin, Antonio Simone Laganà, Paolo Moghetti, Mario Montanino Oliva, Vittorio Unfer, Annamaria Colao